Clear Cell Adenocarcinoma — Trials

Clear Cell Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

362 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 150
Recruiting: 79
Ph III recruiting: 9
Growth YoY: −15.8%
Industry share: 24%
Top sponsor: National Cancer Institute (NCI)
Termination share: 39.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (53)

clinicaltrialsPublishedShowing 351–362 of 362 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02247583	Investigating Patient Satisfaction With Oral Anti-Cancer Treatment(IPSOC)	completed	—	90	KU LeuvenOTHER	1	Sep 25, 2014	clinicaltrials
NCT00303862	AZD2171 in Treating Patients With Refractory Metastatic Kidney Cancer	terminated	Phase 2	10	National Cancer Institute (NCI)NIH	1	May 21, 2014	clinicaltrials